Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised HOCHDORF Holding AG on the deal. Schellenberg Wittmer advised SIX Swiss Exchange-listed HOCHDORF Holding AG, a Swiss market leader in milk processing, specialising...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
You must be a Standard 1 Year member to access this content.
